Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS.
Patrick BlinCaroline Dureau-PourninJacques BénichouYves CottinPatrick MismettiAbdelilah AbouelfathRegis LassalleCécile DrozNicholas MoorePublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2020)
European Medicines Agency EUPAS 13017 (www.encepp.eu) Clinicaltrials.gov id NCT02785354.